Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peter King

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioanalysis|November 19, 2010
Criteria for selecting pharmacokinetic repeat study samplesS Peter King, Bruce J Aungst, Huey-Shin L Shen
Antimicrobial Agents and Chemotherapy|June 6, 2007
Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbitsEric G Solon, James A Dowell, Jonghui Lee, et al.
American Journal of Therapeutics|May 14, 2005
Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonideShashank Rohatagi, Yongyi Luo, Liduo Shen, et al.
The AAPS Journal|April 22, 2009
Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendationsDouglas M Fast, Marian Kelley, C T Viswanathan, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Journal of Clinical Pharmacology|May 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioanalysis|November 19, 2010
Criteria for selecting pharmacokinetic repeat study samplesS Peter King, Bruce J Aungst, Huey-Shin L Shen
Antimicrobial Agents and Chemotherapy|June 6, 2007
Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbitsEric G Solon, James A Dowell, Jonghui Lee, et al.
American Journal of Therapeutics|May 14, 2005
Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonideShashank Rohatagi, Yongyi Luo, Liduo Shen, et al.
The AAPS Journal|April 22, 2009
Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendationsDouglas M Fast, Marian Kelley, C T Viswanathan, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Journal of Clinical Pharmacology|May 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Pageof 1